SDF-1 is an antifibrotic mediator in vivo

A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), R. Schliep (Bern, Switzerland), S. Mykoniati ( Delemont,, Switzerland), P. Khan (Basel, Switzerland), K. Hostettler (Basel, Switzerland), L. Knudsen (Hanover , Germany), T. Geiser (Hanover, Germany)

Source: Virtual Congress 2020 – Translational therapeutic advances
Session: Translational therapeutic advances
Session type: E-poster session
Number: 3357
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), R. Schliep (Bern, Switzerland), S. Mykoniati ( Delemont,, Switzerland), P. Khan (Basel, Switzerland), K. Hostettler (Basel, Switzerland), L. Knudsen (Hanover , Germany), T. Geiser (Hanover, Germany). SDF-1 is an antifibrotic mediator in vivo. 3357

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhibitory effect of statins on fibrogenic mediator production from lung cells
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Nintedanib mediates effective modulation of relevant pro-fibrotic biomarkers ex vivo
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019



A decoy CXCL8 with increased glycosaminoglycan binding has potent anti-inflammatory activity in lung inflammation models
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010

Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010


Dimethylfumarate reduces growth factor- and cytokine-induced IL-6 release from human lung fibroblasts: role of (NF)-κB
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008

RB2/p130 gene-enhanced expression downregulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo
Source: Eur Respir J 2002; 20: Suppl. 38, 3s
Year: 2002

Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018

Inhibition of VEGF and MMP-9 production by Pregabalin in human immunocompetent cells in vitro
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020

Human Airway Trypsin-like protease exerts potent anti-fibrotic role in vivo.
Source: International Congress 2017 – Rare diseases
Year: 2017

Profibrotic cytokine TGF-β1 increases endothelial progenitor cell angiogenic properties
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

The PDE4-inhibitors roflumilast and rolipram modulate fibroblast collagen-gel contraction and chemotaxis mediated by autocrine PGE2 synthesis induced by TGF-β1
Source: Eur Respir J 2005; 26: Suppl. 49, 214s
Year: 2005

The effect of recombinant Il-8 on eosinophil migration in vitro and in vivo
Source: Eur Respir J 2002; 20: Suppl. 38, 382s
Year: 2002

In vitro profibrotic effects of rapamycin on basal or TGF-β1 induced primary human lung fibroblast: ECM production and turnover, migration and differentiation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Selective inhibition of COX-2 by celecoxib exerts negative effects on endothelial progenitor cell proliferation and stimulates apoptosis in vitro
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005

Inhibition of chloride channel activity by BMP-2 in lung fibroblasts opposes profibrotic action of endothelin-1
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009


The GLP-1 receptor agonist Liraglutide attenuates intermittent hypoxia-induced pro-inflammatory macrophage polarization in primary macrophages
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021



Adapalene abrogates erlotinib-induced skin disorder by regulating proinflammatory cytokine production from human epidermal cells
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




The anti-inflammatory effects of angiopoietin-1 in mice asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 680s
Year: 2007

Role of transient receptor potential vanilloid 4 in the therapeutic antifibrotic effects of pirfenidone
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019